Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 12.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,695 shares of the company’s stock after acquiring an additional 1,500 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned about 0.08% of Addus HomeCare worth $1,717,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in ADUS. Quarry LP purchased a new stake in shares of Addus HomeCare during the third quarter valued at approximately $28,000. Smartleaf Asset Management LLC grew its holdings in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares during the last quarter. KBC Group NV lifted its stake in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after acquiring an additional 268 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Addus HomeCare by 34.5% during the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock valued at $158,000 after purchasing an additional 323 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $91.24 on Thursday. The firm has a market capitalization of $1.66 billion, a P/E ratio of 20.88, a P/E/G ratio of 1.41 and a beta of 0.97. The business has a 50 day simple moving average of $113.25 and a 200 day simple moving average of $122.39. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Research analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ADUS has been the topic of several recent analyst reports. Oppenheimer upped their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. JMP Securities started coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Stephens reissued an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $132.78.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.